Israel-based endoscope maker 3NT nears goal in $15M fundraising

The venture marks the first investment in an Israeli firm for the Tokyo-based Hoya. (Pixabay)

Israel-based endoscope maker 3NT said it has raised most of a $15 million funding round with backing by Japanese medtech giant Hoya.

The startup, which is located in Rosh Ha’Ayin, Israel, is working on a drivable endoscope for ear, nose and throat procedures it has dubbed Sinusway. Funds from the financing round are expected to go toward commercializing the device in the U.S. and Europe and the completion of 3NT’s pipeline of single-use endoscopes, the company said.

The venture marks the first investment in an Israeli firm for the Tokyo-based Hoya. Previous investors in 3NT include LongTec China Ventures and a consortium of angel investors, medical device industry veterans and ENT practitioners.


Overcoming Risk in Oncology Drug Development

Oncology drug development is full of potential obstacles and risks, and you must carefully plan each step. Download this whitepaper for tips on finding the fast track. Premier Research. Built for Biotech.

"We are honored to have HOYA join our team of investors. their investment is a strong validation of the team's efforts to establish single-use endoscopy platforms as the next standard of care in ENT," Ehud Bendory, 3NT’s chief executive, said in a statement.

In the endoscope arena, Boston Scientific snapped up EMcision for an undisclosed price in March to expand its endoscopic portfolio. That acquisition gave Boston Scientific ownership of an FDA-approved endoscopic device that ablates gastrointestinal tissue using radiofrequency waves.


Suggested Articles

The FDA approved the first spinal tether to correct the most common form of scoliosis—a ropelike implant that pulls the vertebrae into shape.

Agilent launched a new analyzer for research that observes cell behavior in real time while also collecting biosensor information.

Five years after Congress passed a law to reduce unnecessary MRIs and CT scans, federal officials have yet to implement it.